Literature DB >> 17624049

Thalidomide in combination with dexamethasone-induced rhabdomyolysis in a patient with refractory myeloma.

Can Boga, Hakan Ozdogu, Mahmut Yeral, Ebru Kizilkilic, Lulufer Tamer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624049

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


× No keyword cloud information.
  2 in total

1.  Lenalidomide in combination with dexamethasone induced rhabdomyolysis in a multiple myeloma patient treated with pravastatin.

Authors:  Chisako Urata; Mariko Yoshimura; Hidekazu Itamura; Takashi Hisatomi; Yasushi Kubota; Noriyasu Fukushima; Eisaburo Sueoka; Shinya Kimura
Journal:  Int J Hematol       Date:  2011-08-03       Impact factor: 2.490

2.  Rhabdomyolysis in a multiple myeloma patient secondary to concurrent treatment with lenalidomide and pravastatin and to lenalidomide alone.

Authors:  Jaime L Shahan; Lori D Panu; Gerhard C Hildebrandt
Journal:  Int J Hematol       Date:  2012-11-28       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.